Omeros (OMER) Asset Utilization Ratio (2011 - 2026)
Omeros recorded quarterly Asset Utilization Ratio of 0.22 in Q1 2026, down 27.98% quarter-over-quarter from 0.31 in Q1 2025, and down 27.98% year-over-year from 0.31 in Q1 2025.
Omeros' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.22 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 27.98% year-over-year to 0.22; the TTM figure through Mar 2026 stood at 0.22 (down 27.98% YoY), while the FY2020 annual figure was 0.46, down 51.65% from the prior year.
- Asset Utilization Ratio came in at 0.22 for Q1 2026 at Omeros, down from 0.31 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.31 in Q1 2025 to a low of 0.22 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.22 |
| Mar 31, 2025 | 0.31 |
| Sep 30, 2021 | 0.67 |
| Jun 30, 2021 | 0.56 |
| Mar 31, 2021 | 0.42 |
| Dec 31, 2020 | 0.36 |
| Sep 30, 2020 | 0.65 |
| Jun 30, 2020 | 1.06 |
| Mar 31, 2020 | 0.89 |
| Dec 31, 2019 | 0.98 |
| Sep 30, 2019 | 1.11 |
| Jun 30, 2019 | 0.79 |
| Mar 31, 2019 | 0.51 |
| Dec 31, 2018 | 0.35 |
| Sep 30, 2018 | 0.24 |
| Jun 30, 2018 | 0.40 |
| Mar 31, 2018 | 0.53 |
| Dec 31, 2017 | 0.54 |
| Sep 30, 2017 | 0.69 |
| Jun 30, 2017 | 0.90 |
| Mar 31, 2017 | 0.74 |
| Dec 31, 2016 | 0.59 |
| Sep 30, 2016 | 0.60 |
| Jun 30, 2016 | 0.67 |
| Mar 31, 2016 | 0.48 |
| Dec 31, 2015 | 0.30 |
| Sep 30, 2015 | 0.14 |
| Jun 30, 2015 | 0.06 |
| Mar 31, 2015 | 0.02 |
| Dec 31, 2014 | 0.03 |
| Sep 30, 2014 | 0.02 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.02 |
| Dec 31, 2013 | 0.11 |
| Sep 30, 2013 | 0.17 |
| Jun 30, 2013 | 0.21 |
| Mar 31, 2013 | 0.25 |
| Dec 31, 2012 | 0.20 |
| Sep 30, 2012 | 0.26 |
| Jun 30, 2012 | 0.33 |
| Mar 31, 2012 | 0.20 |
| Dec 31, 2011 | 0.15 |
| Sep 30, 2011 | 0.11 |